News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
218 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2854)
February (3083)
March (3049)
April (3166)
May (3576)
June (3256)
July (3084)
August (3051)
September (3627)
October (3996)
November (3760)
December (3171)
Day
3 (232)
4 (249)
5 (228)
6 (307)
7 (212)
10 (218)
11 (212)
12 (245)
13 (219)
14 (193)
17 (255)
18 (207)
19 (212)
20 (188)
21 (132)
24 (173)
25 (158)
26 (120)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
3
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
25
26
Policy
Emergent BioSolutions Seeks Expanded Biothrax Label; Submits FDA Application For Post-Exposure Prophylaxis
November 10, 2014
·
5 min read
Business
Inovio Pharmaceuticals Reports 2014 Third Quarter Financial Results
November 10, 2014
·
9 min read
Business
Transition Therapeutics Inc. To Hold Conference Call On First Quarter Fiscal 2015 Financial Results On Wednesday, November 12th, At 4:30 P.M. EST
November 10, 2014
·
2 min read
Business
Soligenix Reports Third Quarter 2014 Financial Results, Highlighted With The Acquisition Of SGX301, Synthetic Hypericin, For The Treatment Of Cutaneous T-Cell Lymphoma
November 10, 2014
·
10 min read
Business
Mirati Therapeutics Reports Third Quarter 2014 Financial Results And Provides Business Update
November 10, 2014
·
5 min read
Business
BioSpecifics Technologies Corporation Third Quarter 2014 Financial Results
November 10, 2014
·
7 min read
BioMidwest
Centene Corporation To Provide 2015 Financial Guidance And Host Investor Meeting In NYC On December 12, 2014
November 10, 2014
·
1 min read
Drug Development
Bristol-Myers Squibb Company Release: Phase 3 UNITY Trials Demonstrate High Cure Rates For Investigational, All-Oral Daclatasvir TRIO Fixed-Dose Combination In Genotype 1 Hepatitis C Patients, Including Those With Cirrhosis
November 10, 2014
·
7 min read
Policy
FDA Accepts Amgen’s Biologics License Application For LDL Cholesterol-Lowering Medication Evolocumab
November 10, 2014
·
12 min read
Genetown
Boston Children’s Hospital Release: Majority Of Obese Teens Already Obese Before Adolescence
November 10, 2014
·
4 min read
Previous
6 of 22
Next
